Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 301 - 350 out of 6,974

Document Document Title
WO/2009/017261A1
The present invention relates to a method for preparing ultrafine p-dioxanone. The method comprises the steps of performing dehydrogenation cyclization of diethylene glycol in the presence of a pure silica catalyst (SiO ) or a copper-chr...  
WO/2009/010527A1
The present invention relates to a process for preparing cyclic glycerol acetals or cyclic glycerol ketals or mixtures thereof and cyclic glycerol monoester acetals or monoether acetals or cyclic glycerol monoester ketals or monoether ke...  
WO/2009/004990A1
It is intended to provide a prostaglandin F2α receptor agonist (FP receptor agonist), which comprises a biphenyl derivative represented by the following general formula (I) (wherein m represents an integer of 0 to 2; n represents an int...  
WO/2008/155818A1
A preventive or therapeutic agent for frequent urination and urinary incontinence containing as an active ingredient, a 1,4-benzodioxine derivative represented by the general formula (I): (wherein A represents an aryl group or a C3-8 cyc...  
WO/2008/148853A1
The present invention relates to novel compounds of formula (I) or a pharmaceutically acceptable salt or solvate thereof, wherein: each R1 is independently selected from the group consisting of Cl, Br, CH3 and CF3; X is carbon or nitroge...  
WO/2008/150486A2
A compound is represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof. A pharmaceutical composition comprises a compound represented by Structural Formula (I) or a pharmaceutically acceptable salt thereof. A ...  
WO/2008/150486A3
A compound is represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof. A pharmaceutical composition comprises a compound represented by Structural Formula (I) or a pharmaceutically acceptable salt thereof. A ...  
WO/2008/145941A9
The invention relates to a conjugated process for the production of nitriles and/or of fatty amines and of polyol carbonates from a natural oil, comprising the following zones: I) zone of methanolysis or hydrolysis of a natural oil conta...  
WO/2008/145941A2
The invention relates to a conjugated process for the production of nitriles and/or of fatty amines and of polyol carbonates from a natural oil, comprising the following zones: I) zone of methanolysis or hydrolysis of a natural oil conta...  
WO/2008/145941A3
The invention relates to a conjugated process for the production of nitriles and/or of fatty amines and of polyol carbonates from a natural oil, comprising the following zones: I) zone of methanolysis or hydrolysis of a natural oil conta...  
WO/2008/139467A2
The present disclosure provides processes for the preparation of lipid conjugated cyclic carbonate derivatives. More specifically, the present disclosure is based on the finding that reacting lipids, such as, ceramides, with N,N'-disucci...  
WO/2008/139467A3
The present disclosure provides processes for the preparation of lipid conjugated cyclic carbonate derivatives. More specifically, the present disclosure is based on the finding that reacting lipids, such as, ceramides, with N,N'-disucci...  
WO/2008/136378A1
Disclosed is a compound represented by the following general formula: (wherein R1 represents a hydrogen atom or the like; R2 represents an optionally substituted alkyl or aryl group or the like; R3 and R4 may be the same or different and...  
WO/2008/134058A1
A dechalcogenative method for the preparation of an allylic sulfide comprises contacting an activated chalcogenide of Formula (I) with a thiol of Formula (II) for a period of time sufficient to form an intermediate of Formula (III), and ...  
WO/2008/125342A3
The present invention relates to novel vanilloid receptor ligands, a method for the production thereof, pharmaceuticals containing said compounds, and the use of said compounds for the production of pharmaceuticals.  
WO/2008/125342A2
The present invention relates to novel vanilloid receptor ligands, a method for the production thereof, pharmaceuticals containing said compounds, and the use of said compounds for the production of pharmaceuticals.  
WO/2008/117305A3
The present invention provides process for the preparation of novel intermediates of (S)-Pregabalin. The present invention also provides process for the preparation of (S)-Pregabalin or a pharmaceutically acceptable salt or solvate there...  
WO/2008/117305A2
The present invention provides process for the preparation of novel intermediates of (S)-Pregabalin. The present invention also provides process for the preparation of (S)-Pregabalin or a pharmaceutically acceptable salt or solvate there...  
WO/2008/118935A1
Processes and intermediates arc provided for the preparation of substituted aminomethyl 2,3,8,9-tctrahydiO-7H-1.4-dioxino[2.3-e]indo]-8-ones of the Formula (A) wherein the variables n, R and R3 are as described herein. Such compounds are...  
WO/2008/109601A2
The transient response of a switching power supply is improved by providing one or more supplemental power sources connected to the output terminal of the power supply. In one embodiment additional current is provided when a sudden incre...  
WO/2008/105286A1
Disclosed is a novel compound, namely a pentacyclic liquid crystal compound having a CF2O bonding group, which has general physical properties necessary for a compound, stability against heat and light, a wide temperature range of a liqu...  
WO/2008/102607A1
Disclosed is a method for the purification of a cyclic ester which comprises the steps of: mixing a co-effluent of a cyclic ester produced by the depolymerization with heating of a hydroxycarboxylic acid oligomer in the presence of a dep...  
WO/2008/089461A1
Specifically useful stereoisomers of 1,3-dioxane derivatives are described and their use in the treatment of a disease or condition dependent on PPAR modulation, such as diabetes, cancer, inflammation, neurodegenerative disorders and inf...  
WO/2008/089462A3
The present invention relates to compounds containing 1,3-dioxane moiety, pharmaceutical compositions thereof, and the use of the compounds and compositions for the modulation of thromboxane A2 or a peroxisome proliferator-activated rece...  
WO/2008/088487A2
Phosphorus-sulfur compounds have flame retardant activity in organic polymer systems. The phosphorus-sulfur compounds can be represented by the structure: Formula (I) wherein X is oxygen or sulfur, T is a covalent bond, oxygen, sulfur or...  
WO/2008/088487A3
Phosphorus-sulfur compounds have flame retardant activity in organic polymer systems. The phosphorus-sulfur compounds can be represented by the structure: Formula (I) wherein X is oxygen or sulfur, T is a covalent bond, oxygen, sulfur or...  
WO/2008/080822A1
The present invention relates to methods of subjecting a mixture of stereoisomers to epimerization and optionally recrystallization procedures to obtain a desired stereoisomer in high yield and purity. Relying upon solubility differences...  
WO/2008/080823A1
The present invention relates to methods of reducing ketal acids, salts and esters to form corresponding ketal alcohols. More particularly, the reducing methods convert the ketal acids, salts, or esters to ketal alcohols by using a reduc...  
WO/2008/080824A1
The present invention advantageously provides ketal functional compounds that can be strong electrophiles under conditions compatible with ketal groups, are stable, crystalline solids at room temperature, and are much safer to handle tha...  
WO/2008/078762A1
Disclosed are: a study on the synthesis of a novel N-(2-aminophenyl)benzamide derivative having an urea structure and represented by the general formula (1); and the utilization of the pharmacological activity of the derivative. A compou...  
WO/2008/075165A1
An improved synthesis for the preparation of [R-(R*, R*)]-2-(4-fluorophenyl)- β, δ-dihydroxy-5-(1- methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1 H-pyrrole-1-heptanoic acid or a pharmaceutically acceptable salt thereof, as well as o...  
WO/2008/075353A1
The present invention relates to sulfonamide derivatives of formula (I) (wherein R1, R2, R3, R3', R4and R5are as defined in the claims), to pharmaceutical compositions comprising the same, and to uses thereof. Compounds of the invention ...  
WO/2008/071776A3
The raw material used in m ost process for the production of cyclic diesters of alpha - hydroxiacids, such as Lactide and Glycolide, is a 10% solution of Hydroxyacid. During the evacuation of the solution and condensation reaction water,...  
WO/2008/071776A2
The raw material used in m ost process for the production of cyclic diesters of alpha - hydroxiacids, such as Lactide and Glycolide, is a 10% solution of Hydroxyacid. During the evacuation of the solution and condensation reaction water,...  
WO/2008/067911A1
The invention relates to new compounds of the formula (I) in which W, X, Y, Z and CKE have the meanings given above, to a plurality of processes and intermediates for their preparation and to their use as pesticides and/or herbicides, an...  
WO/2008/061871A1
The present invention relates to ketomethionine ketals or hemiketals and their derivatives and also their preparation and their use as fodder additives, in particular for the nutrition of ruminants.  
WO/2008/061821A1
The present invention relates to a process for preparing tetramethyl glycolide, in which a composition comprising at least 50% by weight of 2-hydroxyisobutyric acid and/or tetramethyl glycolide is heated to a temperature of at least 100°C.  
WO/2008/058402A1
The invention is directed to compounds and methods for treating protein folder disorders. In certain embodiments the invention provides compounds and methods for treating neurodegenerative diseases such as Alzheimer's disease, tauopathy,...  
WO/2008/052086A1
Compounds are described herein which are agonists or partial agonists of the 2C subtype of brain serotonin receptors. The compounds have the formula I: or pharmaceutically acceptable salts thereof, wherein each of A, R1, R2, R3, R4, Ra, ...  
WO/2008/047651A1
Disclosed is a process for producing flake-like dried DOG. In the process, DOG having a liquid content of 10 to 50 mass% is subjected to a continuous melting/drying step under specific conditions. The resulting product is subjected to a ...  
WO/2008/043947A1
The invention relates to a method for the synthesis of cyclic acetals that comprises reacting at least one carbonyl-function compound selected from aldehydes, ketones and/or linear acetals, on a polyol in a concentrated aqueous solution ...  
WO2008013550A8
Novel substituted phenylsulfur trifluorides that act as fluorinating agents are disclosed. Also disclosed are methods for their preparation and methods for their use in introducing one or more fluorine atoms into target substrate compounds.  
WO/2008/031157A1
The present invention relates to a class of acetylenic compounds, to a method of preparing the acetylenic compounds, and to the polymerisation and therapeutic uses of the acetylenic compounds. The invention particularly relates to compou...  
WO2006024627A9
The N-oxide forms, the pharmaceutically acceptable addition salts and the stereochemically isomeric forms thereof, wherein n is 1, 2, 3, or 4; Z represents O, S, NR6, SO or SO2; R1 represent hydrogen, cyano, hydroxy, or C1-4alkyl optiona...  
WO/2008/016199A1
The present invention relates to a process for the preparation of chiral 2-hydroxymethyl-l,4-benzodioxane compound. The method in accordance with the present invention comprises the steps of reacting chiral epihalohydrin or chiral glycid...  
WO/2008/015885A1
Disclosed is a method for purifying a hydroxycarboxylic acid by distillation, which is characterized by distilling an aqueous hydroxycarboxylic acid solution containing a high boiling point hydroxy compound which is composed of at least ...  
WO/2008/011742A1
A method of using organic compounds and providing slow release flavoring in or for food products wherein flavor precursors are added to flavor compositions and/or food products and release flavor compounds upon consumption of the food pr...  
WO/2008/012950A1
Disclosed are: a composition useful for the detoxification of a toxic compound containing arsenic or the like efficiently and systematically; and a method for the detoxification of a toxic compound using the composition. Specifically, di...  
WO/2008/013550A1
Novel substituted phenylsulfur trifluorides that act as fluorinating agents are disclosed. Also disclosed are methods for their preparation and methods for their use in introducing one or more fluorine atoms into target substrate compounds.  
WO/2008/010455A1
Disclosed is a method for producing a β-diaryl electron-withdrawing group substituted compound at high yield with high selectivity. Specifically, an optically active β-diaryl electron-withdrawing group substituted compound represented ...  

Matches 301 - 350 out of 6,974